Letter: Serum HBcrAg Is a Useful Marker for Disease Monitoring, Predicting Treatment Response and Disease Outcome of Chronic Hepatitis B Virus Infection-Authors' Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Transient Elastography Is Useful for Evaluating Hepatocellular Carcinoma Development During Entecavir Treatment of Chronic Hepatitis B Virus Infection

Gastroenterology, Hepatology and Endoscopy
2017English

Letter: Tenofovir Disoproxil Fumarate Is Safe for Prevention of Mother-To-Child Transmission of Hepatitis B Virus. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Serum HBV RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection

Hepatology
MedicineHepatology
2019English

Treatment of Chronic Hepatitis B Virus Infection With Rebavrin.

BMJ
1977English

Hepatitis G Virus Infection in Chronic Liver Disease

Gut
Gastroenterology
1998English

Letter: Lipid-Lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-More Evidence Is Needed. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

A Serum MicroRNA Signature Is Associated With the Immune Control of Chronic Hepatitis B Virus Infection

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy